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Lepow et al. (1) and Naff et al. (2) showed that the first component of human com- 
plement is a  macromolecule composed of three "subcomponents"  which they called 
Clq, Clr, and Cls. Clq was shown to be the same protein as the previously described 
llS component (3), Clr was introduced as a  new component, and Cls was identified 
as the proesterase or precursor of the esterase activity associated with C1. All of these 
subcomponents were found to be required for C1 to be hemolyticaUy active. In serum, 
hemolytic C1 was found to have a molecular size of approximately 18S and could be 
rendered hemolytically inactive by dissociating it into its "subunits" or components 
by a calcium chelating agent (1, 2). This suggested that in normal serum the subunits 
of C1 existed in a macromolecular complex, the structural and functional integrity of 
which seemed dependent on the presence of Ca  ++. 
To date, information concerning the relationship of the subcomponents of C1 
to the whole molecule and to each other has been derived from in  vitro experi- 
ments dependent on the use of calcium chelating agents  to dissociate the sub- 
components. It is the purpose of this report to describe studies of Clq, Clr, and 
Cls in a human serum found to be extremely deficient in hemolytic C1 activity. 
These  studies  show  that  the  deficiency is predominantly related to  a  severe 
deficiency or absence of Clr and that the other subunits of C1,  though present 
in  normal  or moderately reduced  amounts,  do  not  react  to  form  a  complex 
(Clq-Cls) when  Clr is deficient. 
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The information derived from the study of this serum suggests that the syn- 
thesis and assembly of the subcomponents of C1 are the functions of more than 
one cell type or perhaps are under separate genetic control. 
Materials and Methods 
Salts  of  Ethylenediaminetetraacetic  Acid  (EDTA)1.--Reagent  grade  Na2H2EDTA  was 
titrated to pH 7.4 at a stock concentration of 0.15 ~t resulting in a solution largely in the form 
NabHEDTA.  Na2MgEDTA  (Geigy  Chemical Corp., Ardsley, N.  Y.)  was also  titrated to 
pH 7.4 at a stock concentration of 0.15 ~t. 
Buffers.--Triethanolamine-buffered  saline  (TBS)(1)  at pH 7.4,  ionic strength 0.15,  con- 
taining 10  -3 ~  Ca  + and 0.05% gelatin (Knox Gelatine, Inc., Camden, N. J.) was used in all 
experiments unless stated otherwise. Veronal-buffered saline at pH 7.4 containing Ca  ++, Mg  +, 
and gelatin were prepared according to Mayer (4). 
Human  Serum.--Human  blood was allowed  to clot at room temperature for 1 hr, stored 
overnight at 5°C,  and  the serum removed after centrifugation at 0°C.  Pools from several 
donors were frozen in portions and stored at  --70°C. 
Human  C1  Subcomponents.--Clq,  Clr,  and  Cls  were  prepared  by  diethylaminoethyl 
(])EAE)-cellulose chromatography of euglobulin  preparations in the presence of Na3HEDTA 
as  described previously (1).  Pools of  these three preparations were dialyzed against TBS 
buffer at I°C for 16 hr to reduce the EDTA concentration to 10-  8 M; for purposes of expressing 
dilutions, these pools were considered undiluted. 
Resolution of  a  euglobulin preparation from the Cl-deficient serum was carried out on 
DEAE-cellulose by this same method (1). 
Guinea Pig C2.--Partially purified C2  was prepared from guinea pig serum  (Texas Bio- 
logical  Laboratory, Inc., Fort Worth, Texas)  according to the method described by Nelson 
(5). 
Sensitized Sheep Erythrocytes (EA).~Sheep blood was collected and processed as previ- 
ously described (1). 
EAC1.--Cell intermediates carrying guinea pig C1  were prepared according to methods 
previously described (6). 
EAC1, 4 and EAC4.--Cell intermediates carrying these components were prepared from 
human serum according to the method described by Borsos and Rapp  (7). 
Assay  of C1 Subcomponents.--Clq,  Clr, and Cls were measured as previously described 
(1, 2). Briefly, buttons of EA containing 5 X  10 s cells were suspended in 0.5 ml of the sample 
to be tested for a given subcomponent. Portions of 0.5 ml of 1/100  dilutions (in TBS) of the 
other two subcomponents  were then added. After incubation for 10 min at 37°C, the resulting 
EAC1  were lysed by adding 2.5  ml  of human  serum  diluted  (1/62.5)  in TBS  containing 
Na2MgEDTA  (final concentration of 16  X  10  -3 M) and allowing  an additional 60 min incu- 
bation at 37°C. 
An alternative method was employed on some occasions with identical results. A button 
of EAC4 (5  X  107 cells) was suspended in 0.5 ml of the test material. The appropriate two 
of the three subcomponents were added and,  after 10  min at 37°C,  0.5  ml of functionally 
purified guinea pig C2 containing 100  (50%)  hemolytic units was added. This was followed 
by incubation for a period of 15  rain at 30°C.  The resulting EAC142  were lysed by adding 
0.5  ml of 1/12.5  dilution of guinea pig complement (GPC) in 0.04 ~  EDTA and allowing  a 
further incubation for 60 rain at 37°C. Mter this incubation, 5.0 ml of chilled  isotonic saline 
were added, and the tubes centrifuged at 0°C. 
i Abbreviations used in this paper: EA, sensitized sheep erythrocytes; EDTA, ethylenedi- 
aminetetraacetic acid;  DEAE,  diethylaminoethyl; TBS,  triethanolamine-buffered saline. PICKERING, I~AFF, STROUD~ GOOD, AND  GEWURZ  805 
In each case, the oxyhemoglobin in the supernate was determined spectrophotometrically, 
at 541 m/z in the first method and 412 m/z for the second. 
Assay of Human  C1, C4, C2, and C3-9.--These activities were determined according to 
methods previously described (6). 
Sucrose Density Gradient.--Linear  sucrose gradients were prepared using 5%-20% (w/v) 
sucrose in TBS with Ca  ++ or with EDTA allowing the gradient to form under gravity flow 
from the mixing chamber. Immediately preceding each run, 0.1 ml of serum was layered on 
the gradient. 
A Beckman Model L-2 preparative ultracentrifuge and a swinging bucket rotor (SW 39 L) 
were used for all experiments, and centrifugation was performed at 35,000 rpm for 15 hr. 
Gradient fractions were obtained by placing a 25 gauge needle into the bottom of the tube 
and with a constant flow pump, filling the tube from the bottom with a 50% sucrose solution. 
This gently moves the entire gradient up through a monitor which records optical density at 
280 m/z; twenty 0.3 ml fractions were collected, diluted in 3.0 ml of chilled 0.15 •  NaC1 solu- 
tion, and dialyzed at 0°4°C overnight against TBS buffer. 
Protein Quantitations.--Complement  component protein concentrations were determined 
by radial immunodiffusion  method of Mancini et al. (8). 
Clq.--Antibody  to  this  component was prepared  by a modification (9)  of  the  method 
described by Morse and Christian  (10). 
Cls.--These determinations were performed using an antiserum to  purified Cls prepared 
as previously described (11). 
C3.--The protein concentration of this component was determined by using commercial 
antibody to C3 obtained from Hyland Laboratories, Los Angeles, Calif. 
C4.--Anfiserum to this component was obtained from Hyland Laboratories. 
RESULTS 
The serum which provides the basis for this study was obtained from a  13-yr 
old child with a form of chronic glomerulonephritis. The severe limitation in the 
ability of this serum to lyse optimally sensitized sheep erythrocytes is due to a 
deficiency of hemolytic C1  (Table I). In addition to showing that the Cl-defi- 
cient serum has normal hemolytic activity of C2 and C3-9, Table I  shows that, 
in the same serum, the concentration of Clq and C3 proteins are normal while 
the concentration of Cls is approximately 30 %-40 % of normal. In contrast, C4 
protein concentration (Table I) and hemolytic activity (Table I  and Fig. 1) and 
C1 esterase inhibitor activity are substantially greater than normal. The basis 
for the increase in amount and function of C4 is not clear, but it is possible that 
Clr and/or Cls play a regulatory role in the normal catabolism or synthesis of 
C4. In order to establish whether the deficiency in hemolytic function is entirely 
attributable to the deficiency of C1, the following experiments were performed. 
Equal volumes of EA, EAC1,  2 or EAC48 were added to appropriate dilutions of 
serum at 30°C. The cells were kept in even suspension by constant gentle agita- 
tion, and samples of 1.0 ml (7.7 X  l0  T  cells) were taken at intervals and added to 
1.5 ml of chilled guinea pig complement (1/37.5) in 0.04 ~  EDTA. Incubation 
Prepared  by adding approximately  100 effective molecules of partially purified guinea 
pig C1 per cell. 
3 EAC14 prepared from these cells showed maximum reaction with C2 to form EAC142 
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for 90 min at 37°C was followed by addition of 5.0 ml of 0.15 M NaC1 solution, 
centrifugation at 0°C,  and determination of supernate oxyhemoglobin spectro- 
photometrically at 412 m#. 
The  results  as shown  in  Fig.  2 a  emphasize  the marked  deficiency of  this 
serum, even at high concentrations, in forming EAC142 from EA or EAC4. Fig. 
2 b  shows that provision of C1  in the form EAC1  provides conditions which 
permit a  rate and degree of EAC142 formation from this serum that is essen- 
tially the same as observed with normal serum. 
Studies of Hemolytic Activity of the C1 Subcomponents.--Euglobulin  prepared 
from this serum by methods previously described (1, 2) was found to be hemo- 
TABLE I 
Hemolytic  Complement Component Activities  and Sdected  Component Protein  Concentrations 
in C1-De ¢cient and Normal Human Serums 
:C H (patient) 
Nml (1) 
Nml (2) 
Nml (3) 
CHso* 
<i 
45 
52 
58 
Clg 
~'d00 
21,000 
27,000 
30,000 
C4;t 
60,000 
18,000 
25,000 
21,000 
c2~  ca-95 
500  120 
450  100 
620  135 
550  110 
Clq 
protein 
~g 
N/ml 
18 
18 
24 
22 
Cls 
protein 
~g/ml 
16¶ 
32.8** 
32.8** 
32.8** 
c4 
protein 
~g 
N/ml 
95 
30 
41 
35 
C3 
protein 
mg/lO0 
ml 
125 
110 
155 
125 
Cl-es- 
terase 
inhib- 
itor§ 
units/ 
ml 
18-24 
6-8 
6-8 
6-8 
* CI-~0 units/m1. 
CI-Is0 units/0.5 ml. 
§ These values were obtained through the courtesy of Dr. J. Pensky. The units expressed 
are those defined in reference 20. 
It CC, C1 deficient serum; Nml, normal human serum. 
¶ Mean of six determinations. Lowest values was 13, the highest was 31 over a period of 
lyr. 
** Normal mean. The normal range (4- 2 SD) =  20.4-45.2. 
lyrically inactive when  assayed for  C1.  Combination  of the  euglobulin  with 
preparations of hemolytically active Clq, Clr, or Cls (Table II) indicated that 
the addition of Clr alone reconstituted the hemolytic activity. When similar 
combinations of subcomponents were added to whole serum the total hemolytic 
complement activity was restored to normal by Clr alone. Addition of Clq, Cls, 
or combination of these subcomponents made no appreciable difference in total 
serum complement activity. 
Chromatography on DEAE-cellulose substantiated this observation. Fig. 3 b 
is  a  representative  elution  pattern  of  protein  and  subcomponent  activities 
derived from  resolution of a  normal  euglobulin  on  DEAE-cellulose. Fig.  3 a 
shows the resolution of a  euglobulin preparation from the Cl-deficient serum. 
Hemolytically active Clq and Cls are dearly present in the latter though Cls PICKERING~ NAFF~ STROUD~ GOOD~ AND  GEWURZ  807 
activity is relatively less than normal. Clr hemolytic activity could not be de- 
tected in any of the fractions from two column runs. Fractions from the Clq 
range (fraction 12) and the Cls range (fraction 115) of one of these two columns 
produced no C1 activity when combined with any of the other fractions from 
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FIG. 1. The dose response curve of C4 hemolytic activity in three representative normal 
human serums (O  O,  •  •,  ,---~)  and  in  the  Cl-deficient human serum 
(A  i)  are shown. 
the same column but led to substantial  formation of C1 when combined with 
known Clr (Table III). 
Since the three subcomponents of C1 appear to be bound together in a macro- 
molecular complex in normal serum, it was of interest to know what relationship 
two of the three subcomponents might have to each other in the apparent ab- 808  DEFICIENCY  OF  clr  IN  HUMAN  SERUM 
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FIc. 2.  (a). Rate and degree of SAC142 formation by normal human serum (1/300 dilution) 
from EA  O  ©  and EAC4  •  O;  and by Cl-deficient human serum  (1/10  dilution) 
from  EA  []  []  and  EAC4  n--~.  (b).  Rate  and  degree  of  SAC142  formation  by 
normal human serum (1/500  dilution)  •  •  and Cl-deficient human serum (i/500  dilu- 
tion)  H  from EAC1. 
TABLE  II 
Reconstitution of Hemolytic C1 Activity in the Euglobulin  from C1-Deficient Human Serum 
Euglobulin (1/50)  Clq (I/t00)  Clr (1/100)  Cls (1/100)  OD (541 m#) 
ml  ml  ml  ml 
0.5  0.5  --  0.5  0.030 
1.0  --  0.5  --  1.040 
0.5  --  0.5  0.5  1.110 
1.5 
--  --  0.020 
These  reagents were  added  to  EA,  incubated  for  10  min at  37°C,  and  resulting EAC1 
were lysed with human serum Na  MgEDTA  as described in  Methods. PICKERING~  NA~'F: STROIYD~ GOOD~ AND  GEWLrRZ  809 
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FIG. 3.  (a).  The elution pattern from DEAE-cellulose chromatography of euglobulin pre- 
pared from Cl-deficient human serum. The starting phosphate buffer  (ionic strength 0.15) 
and the limiting buffer  (ionic strength 0.5)  contained  10  -8 ~r Na3 EDTA. The gradient was 
begun at fraction 21. These conditions were identical for all DEAE columns. The hemolytic 
activities of Clq  (O  O)  and  Cls  (A  A)  were observed  in the fractions indicated. 
No  Clr  (~  activity  was  detected.  (b).  The  elution pattern  from  DEAE-cellulose 
chromatography of euglobulin prepazed from normal human serum. The hemolytic activities 
of Clq (O  O), Clr (1  ~),  and Cls (&  A) are present in the fractions asshown. 810  DEFICIENCY  OF  clr  IN  HUMAN  SERUM 
sence of the third. The Cl-deficient serum, with no detectable Clr function, was 
fractionated by sucrose density gradient ultracentrifugation in an  attempt  to 
obtain information pertaining to this question. 
It has been shown previously that when  normal human  serum is subjected 
to centrifugation in a sucrose gradient, hemolytically active C1 sediments near 
the 19S region (2). Fig. 4  a  shows that when normal human serum was centri- 
fuged in a sucrose gradient containing Ca  ++, whole C1 activity was greatest in 
the  fractions  near  the  19S  marker.  No  subcomponents  were  detectable  in 
lighter  fractions.  However,  when  Clr-deficient  serum  was  centrifuged  sim- 
ultaneously,  there  was  no  whole  C1  activity:  Clq  activity was  greatest  in 
fraction 11,  and Cls activity was maximum between fractions 7 and 8, lighter 
TABLE  III 
Recombination of  Subcomponents Derived from  Clr-Deficient  Euglobulin 
Fraction No, 12"  Fraction  115"  Other fraction  (Clq)  (Cls)  Clr:~  TBS  Nos.§  OD 
+  +  -  +  -  0.012 
+  +  -  -  70  0.015 
+  +  -  -  72  0.013 
+  +  -  -  74  0.011 
+  +  -  -  76  0.014 
+  +  -  -  78  0.011 
+  Jr  q-  -  -  0.534 
* 0.5 ml of a  1/50 dilution of the fractions  taken from  the column as  shown in  Fig. 2 a. 
:~ 0.5 ml of a normal Clr preparation (1/100 dilution). 
§ Representative fractions from the region where Clr would normally  elute  (70, 72, 74, 
76, and 78)  have been used as a possible source of Clr. 
than the 7S marker (Fig. 3 b). The location of maximum Clq and Cls activity 
were identical when Cl-deficient serum was centrifuged in the presence of Ca  ++ 
or in EDTA,  and under both conditions there was minimal Clq-Cls  activity 
in fractions 8 and 9 where these two subcomponents overlapped in the gradient. 
The very small amount of Cls activity in the gradient fractions might be the 
result  of  two  circumstances;  namely,  reduced  concentration  of  Cls  protein 
(Table I) and the presence of the Cl-esterase inhibitor which sediments in the 
same region as Cls on sucrose gradient (2). 
These experiments suggest that the relative absence of hemolytic C1 activity 
in this human serum is due predominantly to a  deficit in Clr function, though 
clearly,  Cls  protein  concentration  and  function  are  substantially  less  than 
normal. The lack of detectable Clr function may be due to an actual deficiency 
of Clr or to a  structural defect in the molecule such that it cannot bind with 
either Clq  or Cls. PICKERING~ NAFF~ STROUD~ G00D~ AND GEWURZ  811 
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FI6. 4.  (a).  The sedimentation pattern of hemolytic C1  (m-----~)  activity after sucrose 
density gradient ultracentrifugation of normal human serum in the presence of calcium ions. 
(b).  After sucrose density gradient ultracentrifugation of Cl-deficient human  serum in the 
presence of calcium ions the subcomponents Clq (I  0)  and  Cls  (O  O)  sediment 
independently as indicated. No Clr activity is detectable in any of the fractions (A  -  A). 812  DEFICIENCY  OF  clr  IN  HUMAN  SERUM 
DISCUSSION 
The studies presented here raise important points concerning the basis for 
the severe deficiency of Clr hemolytic activity and the moderate deficiency of 
Cls  hemolytic activity in  the  presence of normal  Clq,  the meaning  of this 
defect in relationship to synthesis of the subcomponents and the relationship 
of the subcomponents Clq and Cls to each other in the relative absence of Clr. 
The lack of other family members with a similar deficiency make it impossible 
to know whether this abnormality is related to a primary or secondary deficit 
in ability to synthesize Clr and to some extent Cls. 
It is of interest that this serum was obtained from a child with chronic glo- 
merulonephritis. The association of the C1 deficiency with this disease is im- 
portant in view of the association of other serum complement aberrations in 
patients with nephritis (9, 12). However, the mechanisms which lead  to these 
serum complement deficiencies in such patients may be varied as suggested by 
observations supporting decreased synthesis (13), increased consumption (13)*, 
and increased urinary loss of complement components (14). Therefore, the fact 
that  this  serum  is  obtained from a  patient  with  chronic  glomerulonephritis 
does not provide any explanation for the basic mechanism which has produced 
such  a  severe deficit of hemolytic  C1. 
Though there is no precedent for selective C 1 deficiency in nephritis, hemoly- 
tic C1 and Clq protein concentration have been found reduced in some forms of 
hypogammaglobulinemia  (15-17),  disorders  known  to  be  associated  with 
defective synthesis of immunoglobulins (18). It has been proposed that these C1 
and Clq deficiencies are likely related to decreased ability to synthesize Clq 
(3,  15-17). In addition, Pondman et al. (19)  described a child with a selective 
deficiency of hemolytic C1 activity related to deficiencies of Cls and Clr. The 
hemolytic activity of the serum was restored by providing purified Cls but not 
by Clq or Clr. Though their patient was presented with a diagnosis of systemic 
lupus erythematosus, there was no mention of any evidence for the presence of 
nephritis. Their observations provide several interesting and important similar- 
ities  to  those  presented here. 
There is no precedent from either in vitro or in vivo studies for a selective 
activation or consumption of one C1  subcomponent and though  this cannot 
be ignored as a possible mechanism for the component deficiency in this serum, 
it seems unlikely. In the serum of our patient, Clr hemolytic activity seemed 
completely dissociated from Clq hemolytic activity and protein concentration. 
The absence of Clr activity was  accompanied by a  lower than  normal  Cls 
activity and Cls protein concentration. Such a concurrence of deficiencies could 
reflect direct linkage of synthesis of Clr and Cls or a more indirect influence of 
Clr on Cls synthesis or degradation. The finding that our patient's serum has 
4 Picketing, R. J., R. C. Herdman, H. Gewurz, H. J. Mfiller-Eberhard, and R. A. Good. 
C3 metabolism  studies in patients with chronic  glomerulonephritis. Unpublished observations. PICKERING, NAFF~ STROUD~ GOOD, AND  GEWURZ  813 
increased C4 hemolytic activity and C4 protein concentration argues that the 
extreme deficiency of C lr and the less profound deficit of C ls are not consequent 
to activation of these subcomponents of C1.  Instead,  this marked increase in 
serum concentration of the component which is a natural substrate  would be 
compatible with deficient activation of Cls by Clr and consequent reduction 
of normal activation of C4. Similarly, the unusually high level of Cl-esterase 
inhibitor activity may result from an accumulation of this protein under con- 
ditions where a subcomponent deficiency precludes normal C1 activation and, 
therefore, reduces utilization of the inhibitor (20). However, it is important to 
note that Cl-esterase inhibitor levels of similar magnitude have been reported 
by Donaldson (21) in patients with azotemia, hypertension, and normal hemo- 
lytic serum complement. Whatever its basis, the striking elevation of C4 protein 
concentrations and hemolytic activity in a patient with virtual absence of C1 
hemolytic activity due to deficiency of Clr stands in contrast to the normal 
concentrations of later acting complement components. 
Increased urinary excretion as a mechanism underlying the decreased serum 
concentration of complement proteins  in renal  disease has  seemed the least 
likely possibility though recently this issue has been raised again (14). 
It seems most likely then, that the C1 deficiency observed in this serum is 
related to an inability, either primary or secondary, of the patient to synthesize 
adequate amounts of Clr and probably Cls. The fact that Clq concentration 
remains normal in the face of a lack of detectable Clr function and reduction 
of Cls activity and Cls protein concentration  suggests that at least two cell 
types are responsible for synthesis and possibly for assembly of macromolecular 
C1. Observations of a similar dissociation in serum from patients with lympho- 
penic hypogammaglobulinemia (22)  and one patient with systemic lupus ery- 
thematosus (19)  support this notion. 
The concept of a macromolecular C1 molecule composed of three subcom- 
ponents requiring calcium ions in order to maintain functional and structural 
stability was first proposed by Lepow et al. (1)  and Naff et al. (2).  Since that 
time the separation of the molecule into its components has remained an in 
vitro  phenomenon  dependent  on  the  chelation  of  calcium  ions  by  EDTA. 
Studies of this Clr-deficient serum indicate that in the relative absence of this 
subcomponent, substantial amounts of the remaining two are present in the 
serum, apparently independent of each other. The observations presented here 
support the original concept of Lepow et al. (1) and Naff et al. (2) by showing 
that, even in the presence of calcium ions, biologic alterations can lead to con- 
ditions which favor dissociation or inefficient assembly of the macromolecule 
with resulting deficient hemolytic activity. It appears that all subcomponents 
are not only essential for C1 function, but that adequate amounts of normal 
Clr  are  essential for assembly and for maintenance of the  macromolecular 
structure. 
Whether Clr protein is absent from this serum, present in a nonfunctional 814  DEFICIENCY  OF  clr  IN  HUMAN  SERUI~i 
form, or in amounts too small to be detected by present functional assays re- 
mains to be determined. 
SITMMARY 
The experiments presented here utilize a human serum markedly deficient in 
hemolytic complement activity to show that:  (a) The hemolytic deficiency is 
the result of a selective deficiency in hemolytic C1.  (b) The relative absence of 
hemolytic C1 is due to a profound deficit in Clr function associated with less 
than  normal  Cls  protein  and  hemolytic  function  and  normal  Clq  protein 
concentration and function. This deficit in Clr in the face of normal Clq sug- 
gests that different cell types are responsible for the synthesis of each of these 
components.  (c)  Whatever  the  basis  for the  deficiency  of Clr  function,  this 
defect results in an inadequate association of the remaining C1 subcomponents, 
Clq  and Cls,  even in the presence of calcium ions,  thus suggesting that Clr 
has an important role in the assembly and/or maintenance of macromolecular 
C1. 
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